Literature DB >> 6378696

Pre-type I diabetes. Linear loss of beta cell response to intravenous glucose.

S Srikanta, O P Ganda, R E Gleason, R A Jackson, J S Soeldner, G S Eisenbarth.   

Abstract

Twenty-one intravenous (i.v.) glucose tolerance tests were performed on nine subjects before the onset of overt type I diabetes mellitus. Islet cell antibodies (6 of 9 subjects) and elevated levels of Ia-positive T-lymphocytes (3 of 3 subjects studied) were detected during the prediabetic period. Elevations of fasting blood glucose and peak glucose during oral glucose tolerance tests were not observed until the year before onset of clinically overt diabetes. During the prediabetic period, there was a progressive loss of early-phase insulin release to i.v. glucose (rate of decline, 20-40 microU/ml insulin release/yr; correlation coefficient, 0.9).

Entities:  

Mesh:

Substances:

Year:  1984        PMID: 6378696     DOI: 10.2337/diab.33.8.717

Source DB:  PubMed          Journal:  Diabetes        ISSN: 0012-1797            Impact factor:   9.461


  55 in total

Review 1.  In vivo imaging of insulitis in autoimmune diabetes.

Authors:  A Signore; M Chianelli; M G Parisella; G Capriotti; P Giacalone; G Di Leve; R Barone
Journal:  J Endocrinol Invest       Date:  1999-02       Impact factor: 4.256

Review 2.  Metabolic abnormalities in the pathogenesis of type 1 diabetes.

Authors:  Shuyao Zhang; Clayton E Mathews
Journal:  Curr Diab Rep       Date:  2014       Impact factor: 4.810

Review 3.  Markers for insulin dependent diabetes: towards early detection.

Authors:  T Wilkin; M Armitage
Journal:  Br Med J (Clin Res Ed)       Date:  1986-11-22

4.  No evidence for increased variation in first phase insulin response to intravenous glucose.

Authors:  B Kuglin; A Hübinger; F A Gries; H Kolb; J Bertrams
Journal:  Diabetologia       Date:  1988-08       Impact factor: 10.122

5.  Variability of the first phase insulin response to intravenous glucose.

Authors:  J S Soeldner
Journal:  Diabetologia       Date:  1988-07       Impact factor: 10.122

Review 6.  Insulin analogues: new therapies for type 2 diabetes mellitus.

Authors:  M Angelyn Bethel; Mark N Feinglos
Journal:  Curr Diab Rep       Date:  2002-10       Impact factor: 4.810

7.  Pre-type 1 (insulin-dependent) diabetes: common endocrinological course despite immunological and immunogenetic heterogeneity.

Authors:  S Srikanta; O P Ganda; R A Jackson; S J Brink; E Fleischnick; E Yunis; C Alper; J S Soeldner; G S Eisenbarth
Journal:  Diabetologia       Date:  1984-07       Impact factor: 10.122

8.  Pre-existing autoimmunity determines type 1 diabetes outcome after Flt3-ligand treatment.

Authors:  Tom L Van Belle; Therese Juntti; Jeanette Liao; Matthias G von Herrath
Journal:  J Autoimmun       Date:  2009-12-09       Impact factor: 7.094

9.  Early metabolic markers of islet allograft dysfunction.

Authors:  David A Baidal; Raquel N Faradji; Shari Messinger; Tatiana Froud; Kathy Monroy; Camillo Ricordi; Rodolfo Alejandro
Journal:  Transplantation       Date:  2009-03-15       Impact factor: 4.939

10.  Segmental pancreatic autotransplantation with pancreatic ductal occlusion after near total or total pancreatic resection for chronic pancreatitis. Results at 5- to 54-month follow-up evaluation.

Authors:  R L Rossi; J S Soeldner; J W Braasch; F W Heiss; J A Shea; F W Nugent; E Watkins; M L Silverman; J Bolton
Journal:  Ann Surg       Date:  1986-06       Impact factor: 12.969

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.